Amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs) are major global causes of death. However, their global incidence ...

The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.

The province made a one-year commitment to pay for Bray’s treatment, which is estimated to cost $300,000 annually. Manitoba ...

Quickly approved by national drug authority Anvisa under priority review, the study positions Brazil at the forefront of the field in Latin America.

Parkinson's disease (PD) is an age-related, progressive neurodegenerative disorder. The hallmark of PD pathogenesis is the ...

A new DoD-funded trial tests SwallowFIT, a targeted therapy that strengthens swallowing muscles in early Parkinson’s patients ...

Recent advances in understanding the brain’s dynamic functioning have been achieved through a wide range of experiments conducted across multiple levels of ...

Based on the characteristics discussed above, let's consider a few potential options and determine which one is not a ...